Trump’s $1M-$5M Axon Stock Buy Precedes ICE’s $220M Taser Contract
AXON•On Feb. 10, Donald Trump purchased $1M-$5M of Axon shares before ICE solicited a five-year, $220M Taser contract requiring the TASER 10’s 45-foot range and 10 probes. Axon, with about 90% of the U.S. Taser market, saw its stock jump over 22%, creating roughly $350K in paper gains.
1. Trump’s Axon Share Purchase
On Feb. 10, former president Donald Trump acquired between $1 million and $5 million of Axon Enterprise shares through a trust managed by his children, though investment decisions were handled by independent advisors. The transaction was disclosed in May, roughly two weeks before U.S. Immigration and Customs Enforcement issued new Taser procurement requirements.
2. ICE’s $220M Taser Solicitation
In late February, ICE sought bids for a five-year, $220 million supply of Tasers featuring a 45-foot effective range and ten individually deployable probes—technical criteria that align closely with Axon’s TASER 10 model and are unlikely to be met by other manufacturers. Axon currently accounts for approximately 90% of all Tasers used by U.S. law enforcement agencies.
3. Axon Stock Performance Post-Notice
Following the ICE notice, Axon shares surged more than 22% at their peak and remained about 7% higher than levels on Trump’s purchase date through June 26. If Trump acquired shares near the top of the reported range, his holding would have generated roughly $350,000 in unrealized gains.
4. Ethics Considerations and Potential Scrutiny
Ethics observers highlight that even without evidence of direct influence, the timing of Trump’s stock purchase relative to ICE’s contract solicitation raises questions about the appearance of conflicts of interest. White House statements emphasize that Trump’s assets are managed independently, but the episode could prompt further scrutiny of procurement processes.
